Registry Studying Laser Treatment for Blocked Heart Arteries
Observes a laser device used to open narrowed heart arteries in adults.
Plain-language title generated from the registry record
Registry title: Coronary Laser Atherectomy Registry From an International Taskforce
Key facts
- Where
- Madrid, SpainSee the site
Where in Spain
- La Paz Universtity HospitalMadrid, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ceric Sàrl
- Trial code
- NCT07348341
- Record updated
- 23 July 2026
- Original description
This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).Read full original descriptionShow less
Coronary Laser Atherectomy Registry From an International Taskforce
This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).
Inclusion: Subjects will be included if all the following criteria are met:; Age 18 years or over; Patient willing to be included in the registry; Patients with stable coronary artery disease or acute coronary syndromes with de-novo or intra-stent restenosis (ISR) coronary lesions suitable to be treated with ELCA; Non-Crossable with ICI catheter or:; Crossable with ICI catheter with significant calcium score suggesting need for calcium modification based on IVUS or OCT criteria and/or; Non-Dilatable with 1:1 NC balloon; Mandated use of ICI:; Attempted before use of ELCA or; Following ELCA and any other calcium modification strategy utilized (to evaluate whether the additional modification demonstrates significant additional modification of the calcium on ICI); Final after DES implantation or prior to use of DCB; Declared PCI strategy (planned use of ELCA, need for IVL/specialty balloons/alternative atherectomy and stent strategy) prior to PCI procedure.
Exclusion: Allergy to clopidogrel, prasugrel or ticagrelor or non-compliance; Post- cardiac arrest or haemodynamic instability; Pregnant or breast feeding; Unable to give informed consent; PCI performed without IVCI attempt; No ELCA use; Participation in another trial.